FOLH1 and adrenal cortex carcinoma: Nevertheless, the authors warrant more studies to encourage a better understanding of using PSMA-targeting radiopharmaceuticals in ACC as diagnostic and theragnostic agents and its integration with conventional imaging in different clinical settings.